A smartphone camera may help emergency doctors spot severe breathing trouble — a trial puts it to the test

NCT ID NCT07726628

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether adding a live video feed from a caller's smartphone camera to standard phone triage helps emergency doctors make better decisions for adults with sudden breathing difficulty. About 778 adults who call a French emergency medical center for acute shortness of breath will be included. The goal is to see if video-assisted triage reduces both under-triage (missing a serious case) and over-triage (sending too many resources).

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
video-assisted medical triage using the caller's smartphone camera
What this could lead to
If it works, this approach could help emergency doctors make faster, more accurate decisions for people with breathing trouble, potentially saving lives and reducing unnecessary hospital visits.
What could go wrong
The trial relies on callers having a smartphone with a working camera and a stable internet connection, which may not always be available. The benefit over standard phone triage may be small or limited to certain situations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 778 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 or over * Contacting the Emergency Medical Communication Center regarding acute dyspnea, respiratory distress or shortness of breath, as the main reason for the call, regardless of the underlying cause * The patient or a bystander must have a mobile phone equipped with a camera and capable of making video calls * Emergency inclusion authorized by the emergency physician responsible for medical regulation in accordance with the emergency consent procedure applicable at the time of the call Exclusion Criteria: * An immediate life-threatening emergency justifying the dispatch of an emergency response team on an automatic basis in accordance with local protocols * Patient at the end of life or where a decision to limit treatment is known at the time of the call. * Refusal to use telemedicine * Lack of a telephone network enabling video consultation. * Patient already included in the study. * Individuals requiring enhanced protection, namely minors, pregnant or breastfeeding women, persons deprived of their liberty by a judicial or administrative decision, and adults under legal guardianship known at the time of the call

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dyspnea are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Dyspnea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University Hospital of Poitiers

    Poitiers, 86021, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.